Bioresorbable Scaffolds Market Size, Share, and Growth Analysis, By Material Type (Polymer-based Scaffolds, Metallic Scaffolds), By Application (Coronary Artery Disease, Peripheral Artery Disease), By End-user, By Region - Industry Forecast 2025-2032
생체흡수성 스캐폴드 시장 규모는 2023년에 17억 1,000만 달러에 달하며, 예측 기간(2025-2032년)의 CAGR은 19.5%로, 2024년 20억 4,000만 달러에서 2032년에는 85억 달러로 성장할 전망입니다.
생체흡수성 스캐폴드 시장은 기술 발전과 심혈관 질환의 유병률 증가로 인해 강력한 성장세를 보이고 있습니다. 이러한 임시 임플란트는 관상동맥 질환을 치료하기 위해 점진적으로 용해되어 혈관의 자연 치유를 허용하도록 설계되어 있습니다. 생체적합성이 높은 고분자 기반 재료가 주류를 이루고 있는 이 시장은 주로 심혈관 치료의 다양한 용도에 적용되고 있습니다. 최종사용자에는 병원, 외래수술센터(ASC), 전문 클리닉 등이 포함되며, 심장 치료 입원 증가가 그 요인으로 작용하고 있습니다. 지역별로는 첨단화된 의료 시스템에 힘입어 북미가 시장 점유율을 주도하고 있으며, 연구 중심의 유럽, 의료 투자와 고령화로 인해 성장하고 있는 아시아태평양이 그 뒤를 잇고 있습니다. 비용과 숙련된 전문가의 필요성 등의 문제에도 불구하고 현재 진행 중인 연구는 향후 유망한 시장 확장을 시사하고 있습니다.
목차
서론
조사 방법
- 정보 조달
- 2차와 1차 데이터 방법
- 시장 규모 예측
- 시장의 전제조건과 제한
개요
- 세계 시장 전망
- 공급과 수요 동향 분석
- 부문별 기회 분석
시장 역학과 전망
- 시장 개요
- 시장 규모
- 시장 역학
- Porter의 산업 분석
주요 시장 인사이트
- 주요 성공 요인
- 경쟁의 정도
- 주요 투자 기회
- 시장 에코시스템
- 시장의 매력 지수(2024년)
- PESTEL 분석
- 거시경제 지표
- 밸류체인 분석
- 가격 분석
- 사례 연구
- 규제 상황
- 특허 분석
생체흡수성 스캐폴드 시장 규모 : 재료 유형별 & CAGR(2025-2032)
- 시장 개요
- 폴리머 기반 스캐폴드
- 금속 스캐폴드
생체흡수성 스캐폴드 시장 규모 : 용도별 & CAGR(2025-2032)
생체흡수성 스캐폴드 시장 규모 : 최종사용자별 & CAGR(2025-2032)
- 시장 개요
- 병원
- 외래 수술 센터
- 심장 카테터 검사실
생체흡수성 스캐폴드 시장 규모 : 지역별 & CAGR(2025-2032)
- 북미
- 유럽
- 독일
- 스페인
- 프랑스
- 영국
- 이탈리아
- 기타 유럽 지역
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- GCC 국가
- 남아프리카공화국
- 기타 중동 및 아프리카
경쟁 정보
- 상위 5사의 비교
- 주요 기업의 시장 포지셔닝(2024년)
- 주요 시장 기업이 채택한 전략
- 최근 시장 동향
- 기업의 시장 점유율 분석(2024년)
- 주요 기업의 기업 개요
- 기업의 상세
- 제품 포트폴리오 분석
- 기업의 부문별 점유율 분석
- 매출의 전년대비 비교(2022-2024)
주요 기업 개요
- Abbott Laboratories(USA)
- Boston Scientific Corporation(USA)
- Medtronic plc(Ireland)
- Terumo Corporation(Japan)
- Biotronik SE & Co. KG(Germany)
- REVA Medical, Inc.(USA)
- Elixir Medical Corporation(USA)
- Amaranth Medical, Inc.(USA)
- Arterial Remodeling Technologies(France)
- Meril Life Sciences Pvt. Ltd.(India)
- Kyoto Medical Planning Co., Ltd.(Japan)
- Lepu Medical Technology(Beijing) Co., Ltd.(China)
- S3V Vascular Technologies(India)
- Zorion Medical(USA)
- ICON Interventional Systems(USA)
- Xenogenics Corporation(USA)
- Arterius Limited(UK)
- SMT(Sahajanand Medical Technologies)(India)
- B. Braun Melsungen AG(Germany)
- Cardionovum GmbH(Germany)
결론과 제안
KSA
Bioresorbable Scaffolds Market size was valued at USD 1.71 billion in 2023 and is poised to grow from USD 2.04 billion in 2024 to USD 8.5 billion by 2032, growing at a CAGR of 19.5% during the forecast period (2025-2032).
The bioresorbable scaffolds market is experiencing robust growth propelled by technological advancements and a rising prevalence of cardiovascular diseases. These temporary implants, designed to treat coronary artery disease by gradually dissolving, allow for natural vessel healing. Dominated by polymer-based materials due to their biocompatibility, the market also addresses diverse applications, predominantly in cardiovascular treatment. End-users include hospitals, ambulatory surgical centers, and specialized clinics, driven by increased cardiac intervention admissions. Geographically, North America leads in market share, supported by advanced healthcare systems, followed by Europe with its research focus, and a growing Asia-Pacific region due to healthcare investments and an aging demographic. Despite challenges like costs and the need for skilled professionals, ongoing research suggests promising market expansion ahead.
Top-down and bottom-up approaches were used to estimate and validate the size of the Bioresorbable Scaffolds market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Bioresorbable Scaffolds Market Segments Analysis
Global Bioresorbable Scaffolds Market is segmented by Material Type, Application, End-user and region. Based on Material Type, the market is segmented into Polymer-based Scaffolds and Metallic Scaffolds. Based on Application, the market is segmented into Coronary Artery Disease and Peripheral Artery Disease. Based on End-user, the market is segmented into Hospitals, Ambulatory Surgical Centers and Cardiac Catheterization Laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Bioresorbable Scaffolds Market
The rising incidence of cardiovascular diseases, including coronary artery disease and peripheral artery disease, significantly propels the growth of the bioresorbable scaffolds market. As these health issues become more prevalent, there is an increasing need for advanced therapeutic options that can effectively restore blood flow. This situation fosters a strong demand for innovative medical solutions, such as bioresorbable scaffolds, which offer unique advantages in the treatment of vascular conditions. The ability of these scaffolds to provide temporary support to blood vessels while gradually dissolving is particularly appealing to healthcare providers looking to improve patient outcomes, further driving market expansion.
Restraints in the Bioresorbable Scaffolds Market
The bioresorbable scaffolds market is confronted with a significant obstacle due to the shortage of long-term clinical evidence. There remains a pressing need for comprehensive evaluations of the performance of bioresorbable scaffold implants in comparison to conventional stents. This lack of conclusive data on their efficacy and safety could hinder healthcare professionals from fully embracing these innovative solutions, potentially affecting adoption rates. As a result, the industry must prioritize the generation of robust clinical studies to substantiate the long-term benefits and reliability of bioresorbable scaffolds, ensuring that they can be confidently integrated into patient care practices.
Market Trends of the Bioresorbable Scaffolds Market
The bioresorbable scaffolds market is experiencing a notable surge, primarily driven by the rising geriatric population, which necessitates enhanced healthcare solutions. As the elderly demographic becomes more predominant, their susceptibility to cardiovascular diseases escalates, creating a substantial demand for innovative treatment options. Bioresorbable scaffolds offer a compelling alternative due to their ability to support vascular structures temporarily and then dissolve, eliminating the need for additional surgical interventions. This trend indicates a shift towards patient-centric approaches in cardiology, with healthcare providers increasingly adopting biocompatible materials to improve patient outcomes and overall quality of life in an aging society.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2024
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
- Case Studies
- Regulatory Landscape
- Patent Analysis
Global Bioresorbable Scaffolds Market Size by Material Type & CAGR (2025-2032)
- Market Overview
- Polymer-based Scaffolds
- Metallic Scaffolds
Global Bioresorbable Scaffolds Market Size by Application & CAGR (2025-2032)
- Market Overview
- Coronary Artery Disease
- Peripheral Artery Disease
Global Bioresorbable Scaffolds Market Size by End-user & CAGR (2025-2032)
- Market Overview
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Catheterization Laboratories
Global Bioresorbable Scaffolds Market Size & CAGR (2025-2032)
- North America (Material Type, Application, End-user)
- Europe (Material Type, Application, End-user)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Material Type, Application, End-user)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Material Type, Application, End-user)
- Brazil
- Rest of Latin America
- Middle East & Africa (Material Type, Application, End-user)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2024
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2024
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
- Abbott Laboratories (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biotronik SE & Co. KG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- REVA Medical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Elixir Medical Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Amaranth Medical, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Arterial Remodeling Technologies (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Meril Life Sciences Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Kyoto Medical Planning Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lepu Medical Technology (Beijing) Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- S3V Vascular Technologies (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Zorion Medical (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ICON Interventional Systems (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Xenogenics Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Arterius Limited (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SMT (Sahajanand Medical Technologies) (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cardionovum GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
